Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: Long-term follow-up
- 20 June 2007
- journal article
- clinical trial
- Published by Elsevier BV in Maturitas
- Vol. 57 (2), 210-213
- https://doi.org/10.1016/j.maturitas.2006.12.004
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine systemContraception, 2005
- Continuous combined parenteral estrogen substitution and intrauterine progestogen delivery: the ideal HST combination?Maturitas, 2005
- Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systemsContraception, 2005
- Assessment of menstrual blood loss in Brazilian users of the frameless copper-releasing IUD with copper surface area of 330 mm2 and the frameless levonorgestrel-releasing intrauterine systemContraception, 2004
- Endometrial safety with a low-dose intrauterine levonorgestrel-releasing system after 3 years of estrogen substitution therapyMaturitas, 2004
- Treatment of nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine systemAmerican Journal of Obstetrics and Gynecology, 2003
- Intrauterine progesterone treatment of early endometrial cancerAmerican Journal of Obstetrics and Gynecology, 2002
- Progestin Treatment of Atypical Hyperplasia and Well-Differentiated Carcinoma of the Endometrium in Women Under Age 40Published by Ovid Technologies (Wolters Kluwer Health) ,1997
- Treatment of Endometrial Cancer with GnRH AnalogsPublished by Springer Science and Business Media LLC ,1992
- Endometrial Morphology During Long-Term Use of Levonorgestrel-Releasing Intrauterine DevicesInternational Journal of Gynecological Pathology, 1986